tiprankstipranks

STEVE PAKOLA Insider Profile

4 Followers
STEVE PAKOLA, CMO at RegenXBio, holds 205.54K shares in RegenXBio (Ticker: RGNX), holds ― shares in Whitehawk Therapeutics (Ticker: WHWK).
tipranks
STEVE PAKOLA

STEVE PAKOLA
RegenXBio (RGNX)
CMO

Not Ranked
STEVE PAKOLA has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
0.00%
A breakdown of STEVE PAKOLA's holdings

Insider Roles

RegenXBio
(RGNX)
CMO
Whitehawk Therapeutics
(WHWK)
CMO
Roles that STEVE PAKOLA holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by STEVE PAKOLA

STEVE PAKOLA's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RegenXBio
Aug 04, 2026
CMO
Uninformative Sell
72.36K
$1.75M
Whitehawk Therapeutics
CMO
List of latest transactions for each holding click on a transaction to see STEVE PAKOLA's performance on stock

STEVE PAKOLA insider profile FAQ

What is the percentage of profitable transactions made by STEVE PAKOLA?
The percentage of profitable transactions made by STEVE PAKOLA is ―.
    What is the average return per transaction made by STEVE PAKOLA?
    The average return per transaction made by STEVE PAKOLA is ―.
      What stocks does STEVE PAKOLA hold?
      STEVE PAKOLA holds: RGNX, WHWK stocks.
        What was STEVE PAKOLA’s latest transaction?
        STEVE PAKOLA latest transaction was an Uninformative Sell of $72.36K.
          What was STEVE PAKOLA's most profitable transaction?
          STEVE PAKOLA’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is STEVE PAKOLA's role in RegenXBio?
            STEVE PAKOLA's role in RegenXBio is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.